AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer

NCT00770848 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Castrate-Resistant Prostate Cancer
Mestastatic Prostate Cancer
Prostate Cancer

Interventions

DRUG: AMG 102
DRUG: AMG 102
DRUG: Mitoxantrone
DRUG: Placebo
DRUG: Prednisone

Sponsor

Amgen